Beydoun, A <br/><br/>
Gabapentin monotherapy: II. A 26-week, double-blind, dose-controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizures. The US Gabapentin Study Group 82/83.  [electronic resource] 

 -  Neurology  Sep 1997 
 - 746-52 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0028-3878 
<br/><br/><label>Standard No.: </label>10.1212/wnl.49.3.746  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetates--administration & dosage<br/>Adolescent<br/>Adult<br/>Ambulatory Care<br/>Amines<br/>Anticonvulsants--administration & dosage<br/>Carbamazepine--administration & dosage<br/>Cyclohexanecarboxylic Acids<br/>Dizziness--chemically induced<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Epilepsy, Complex Partial--drug therapy<br/>Epilepsy, Generalized--drug therapy<br/>Female<br/>Gabapentin<br/>Humans<br/>Male<br/>Middle Aged<br/>Patient Dropouts<br/>Placebos<br/>Treatment Outcome<br/>gamma-Aminobutyric Acid